iRhythm Holdings, Inc. Reports Third Quarter 2026 Financial Results

11/5/2026
Impact: 60
Healthcare

iRhythm Holdings reported third-quarter 2026 revenue of $221.6 million, up 14.9% year over year, with gross margin improving 310 basis points to 74.2%. Adjusted EBITDA was $51.2 million and adjusted net income was $27.8 million, while the company recorded a GAAP net loss of $29.9 million. For full-year 2026, iRhythm expects revenue of $890 million to $895 million, including about $16 million from its VitalConnect acquisition, which closed October 5, 2026. Management cited sustained customer demand and efficiency-driven operating leverage.

AI summary, not financial advice

Share: